China GrandPharma In-Licenses Acetium Capsules from Finnish Company
GrandPharma of China has licensed  China  rights to Acetium capsules from Biohit Oyj, a Finish pharmaceutical company. Acetium reduces the level of acetaldehyde, a carcinogen, in the GI tract. GrandPharma will manufacture and distribute the product in  China , once SFDA approval has been granted, a process that will take about two years. The agreement includes a diagnostic kit that tests for excessive acetaldehyde. Financial details were not disclosed. More details.... Stock Symbol: (HK: 512) Share this with colleagues: // //  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here